Marc Charles Email

Director Clinical Supply Chain . Emalex.

Current Roles

Employees:
22
Revenue:
$3.4M
About
Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. Ecopipam, its first development candidate, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome. The latter is a childhood-onset neurodevelopmental condition characterized by motor and vocal tics for which very few safe and effective therapies exist.
Emalex. Address
330 N. Wabash
Chicago, IL
United States
Emalex. Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.